EFIENT Film-coated tablet Ref.[8071] Active ingredients: Prasugrel

Source: European Medicines Agency (EU)  Revision Year: 2019  Publisher: Daiichi Sankyo Europe GmbH, Zielstattstrasse 48, 81379, Munich, Germany

Product name and form

Efient 10 mg film-coated tablets.

Efient 5 mg film-coated tablets.

Pharmaceutical Form

Film-coated tablet (tablet).

Efient 10 mg: Beige and double-arrow shaped tablets, debossed with “10 MG” on one side and “4759” on the other.

Efient 5 mg: Yellow and double-arrow shaped tablets, debossed with “5 MG” on one side and “4760” on the other.

Qualitative and quantitative composition

Efient 10 mg: Each tablet contains 10 mg prasugrel (as hydrochloride).

Excipient(s) with known effect: Each tablet contains 2.1 mg lactose.

Efient 5 mg: Each tablet contains 5 mg prasugrel (as hydrochloride).

Excipient(s) with known effect: Each tablet contains 2.7 mg lactose.

For the full list of excipients, see section 6.1.

Active Ingredient Description
Prasugrel

Prasugrel is an inhibitor of platelet activation and aggregation through the irreversible binding of its active metabolite to the P2Y12 class of ADP receptors on platelets. Since platelets participate in the initiation and/or evolution of thrombotic complications of atherosclerotic disease, inhibition of platelet function can result in the reduction of the rate of cardiovascular events such as death, myocardial infarction, or stroke.

List of Excipients

Tablet Core:

Microcrystalline cellulose
Mannitol (E421)
Croscarmellose sodium
Hypromellose (E464)
Magnesium stearate

Film-Coat:

Lactose monohydrate
Hypromellose (E464)
Titanium dioxide (E171)
Triacetin (E1518)
Iron oxide red (E172) {only Efient 10 mg}
Iron oxide yellow (E172)
Talc

Pack sizes and marketing

Aluminium foil blisters in cartons of 14, 28, 30, 30 (x1), 56, 84, 90 (x1) and 98 tablets.

Not all pack sizes may be marketed.

Marketing authorization holder

Daiichi Sankyo Europe GmbH, Zielstattstrasse 48, 81379, Munich, Germany

Marketing authorization dates and numbers

Efient 5 mg: EU/1/08/503/001 – 007, 015
Efient 10 mg: EU/1/08/503/008 – 014, 016

Date of first authorisation: 25 February 2009
Date of latest renewal: 13 November 2013

Drugs

Drug Countries
EFIENT Austria, Cyprus, Germany, Estonia, Spain, Finland, France, Ireland, Italy, Japan, Lithuania, Netherlands, Poland, Romania, Tunisia, United Kingdom, South Africa

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.